SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (15094)2/15/1998 2:18:00 AM
From: Torben Noerup Nielsen  Read Replies (1) of 32384
 
Henry,

>at this time the paper does not have a definitive reason on why
>Targretin did so well. Several clinical trials were proposed as well
>as several molecular mechanisms.

While the underlying reason is not all that important in terms of getting the drug to market, it is of great importance for Ligand. If they can unravel the molecular mechanism, they will have gained the high ground since this would open the whole problem up to rational drug design.

Why do I have this feeling that a lot of Ligand's scientists are working feverishly on just that question....

Cheers, Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext